There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Alphatec Holdings (ATEC – Research Report) and Karyopharm Therapeutics (KPTI – Research Report) with bullish sentiments. Alphatec Holdings (ATEC) H.C. Wainwright analyst

In a report released today, Swayampakula Ramakanth from H.C. Wainwright maintained a Buy rating on Alphatec Holdings (ATEC – Research Report), with a price target of $4. The company’s shares closed on Friday at $1.95, equals to its 52-week low

H.C. Wainwright analyst Swayampakula Ramakanth reiterated a Buy rating on Alphatec Holdings (ATEC – Research Report) today and set a price target of $4. The company’s shares closed on Friday at $2.98. Ramakanth said: “We have updated our model to

In a report released today, Swayampakula Ramakanth from H.C. Wainwright reiterated a Buy rating on Alphatec Holdings (NASDAQ: ATEC), with a price target of $4. The company’s shares closed yesterday at $2.74. According to TipRanks.com, Ramakanth is a 4-star analyst

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Alphatec Holdings (NASDAQ: ATEC), Capricor Therapeutics (NASDAQ: CAPR) and DENTSPLY SIRONA Inc (NASDAQ: XRAY) with bullish sentiments. Alphatec Holdings (NASDAQ: ATEC) Alphatec